PMID: 9542903May 23, 1998Paper

Comparison of RapID yeast plus system with API 20C system for identification of common, new, and emerging yeast pathogens

Journal of Clinical Microbiology
A Espinel-IngroffJ Marler

Abstract

The ability to identify yeast isolates by the new enzymatic RapID Yeast Plus System was compared to the ability to identify yeast isolates by the API 20C system. A total of 447 yeast isolates representing Blastoschizomyces capitatus, 17 Candida spp., 5 Cryptococcus spp., Geotrichum spp., 2 Hanseniaspora spp., Hansenula anomala, Hansenula wingei, 3 Rhodotorula spp., Saccharomyces cerevisiae, Sporobolomyces salmonicolor, Trichosporon beigelii, and 2 Prototheca spp. were evaluated. Also, five quality control strains (Candida spp. and Cryptococcus laurentii) with well-documented reactivities by the RapID Yeast Plus System were used. Each isolate was evaluated by both methods with a 48-h culture grown at 30 degrees C on Sabouraud dextrose agar (Emmons modification) by following the recommendations of the manufacturers. The RapID Yeast Plus System enzymatic reactions were read after 4 h of incubation, and the API 20C carbohydrate assimilation identification profiles were obtained after 72 h of incubation. There was good (95.7%) agreement between the identifications obtained by the two methods with the eight common Candida spp. and with Cryptococcus neoformans. The agreement was lower when the emerging Candida spp. and other yeast-lik...Continue Reading

References

May 1, 1979·Journal of Clinical Microbiology·W J BueschingG D Roberts
Sep 1, 1979·Journal of Clinical Microbiology·G A LandJ C Byrd
Sep 1, 1975·Journal of Clinical Microbiology·G A LandJ M Hopkins
Mar 1, 1976·Journal of Clinical Microbiology·G D RobertsG E Hollick
Apr 1, 1991·Journal of Clinical Microbiology·G A LandG Hashem
Oct 1, 1991·Journal of Clinical Microbiology·G St Germain, D Beauchesne
Apr 1, 1987·Journal of Clinical Microbiology·I F SalkinM R McGinnis
May 1, 1996·Journal of Clinical Microbiology·T T KitchP C Appelbaum
Sep 1, 1948·Journal of Bacteriology·L J Wickerham, K A Burton

❮ Previous
Next ❯

Citations

Sep 25, 2014·Journal of the American Animal Hospital Association·Paul M ManinoDerek Burney
Mar 17, 2007·Medical Mycology·D H PincusS Chatellier
Mar 28, 2002·Applied and Environmental Microbiology·Covadonga R AriasMickey E Parish
Feb 2, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christelle BourgeoisKarl Kuchler
Nov 14, 2003·Journal of Medical Microbiology·Min-Chih HsuShu-Ying Li
Jul 21, 2006·Journal of Industrial Microbiology & Biotechnology·S GenteM Gueguen
Apr 13, 2007·Clinical Microbiology Reviews·Cornelia Lass-Flörl, Astrid Mayr
Nov 11, 2003·Comprehensive Therapy·Lewis H McCurdy, Jason D Morrow
Oct 7, 2011·Clinical Microbiology Reviews·Arnaldo L ColomboGuilherme M Chaves
Apr 20, 2016·Critical Reviews in Biotechnology·Mohammadali SafaviehWaseem Asghar
Feb 3, 2007·Journal of Clinical Microbiology·D Jane HataNancy L Wengenack
May 2, 2000·Journal of Clinical Microbiology·B GrafU B Göbel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.